Reval Appoints Steve Rosenberg to Board of Directors

Reval has appointed Steve Rosenberg to its board of directors. Rosenberg is senior vice president of Phase Forward, a provider of data management solutions for clinical trials and drug safety. At Phase Forward, Rosenberg oversees product development, product management, the North American services organisation and the company’s worldwide production hosting operation. Rosenberg has over 27 years experience in the software industry. Prior to Phase Forward, he served as the senior vice president of development and client services at W3 Health, where he led the development and implementation of the company’s flagship healthcare analytics ASP environment, and participated in venture capital activities and sales campaigns. In addition to his professional work, Rosenberg currently serves as chairman of the board of trustees for St. Ann’s Home, a school and residential facility for disturbed and abused children.


Related reading